N-[4-(1,3-Benzoxazol-2-yl)phenyl]-4-(trifluoromethyl)benzamide

Catalog No. :
ACYVDV272
CAS No. :
478081-09-3
Molecular Formula :
C21H13F3N2O2
Molecular Weight :
382.34

IUPAC Name:N-(4-(benzo[d]oxazol-2-yl)phenyl)-4-(trifluoromethyl)benzamide

N-[4-(1,3-Benzoxazol-2-yl)phenyl]-4-(trifluoromethyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[4-(1,3-Benzoxazol-2-yl)phenyl]-4-(trifluoromethyl)benzamide
IUPAC NameN-(4-(benzo[d]oxazol-2-yl)phenyl)-4-(trifluoromethyl)benzamide
MDL No.MFCD02082419
Molecular FormulaC21H13F3N2O2
Molecular Weight382.34
SMILESO=C(NC1=CC=C(C2=NC3=CC=CC=C3O2)C=C1)C4=CC=C(C(F)(F)F)C=C4
InChI KeyKPTHVPMBPFBXLX-UHFFFAOYSA-N
SynonymN-[4-(1,3-BENZOXAZOL-2-YL)PHENYL]-4-(TRIFLUOROMETHYL)BENZENECARBOXAMIDE;N-[4-(1,3-benzoxazol-2-yl)phenyl]-4-(trifluoromethyl)benzamide;N-(4-(benzo[d]oxazol-2-yl)phenyl)-4-(trifluoromethyl)benzamide;Benzamide, N-[4-(2-benzoxazolyl)phenyl]-4-(trifluoromethyl)-
CAS No.478081-09-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACYVDV272 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYVDV272 route product structure diagram
    ACYVDV272478081-09-3
Inquiry

2. ACYVDV272 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEASN653 route compound structure diagram
    ACEASN65325832-58-0 In Stock
  4. Then
  5. ACYVDV272 route product structure diagram
    ACYVDV272478081-09-3
Inquiry

Comments (0)